
Venture Capitalist Jon Medved’s Journey with ALS and the Impact of Israeli Startups
News Summary
Jon Medved, a prominent venture capitalist and a pivotal figure in Israel’s startup ecosystem, has been diagnosed with ALS, also known as Lou Gehrig’s disease. Medved, who founded the innovative crowdsourced venture capital firm OurCrowd, has had to step down due to his diagnosis. Despite this, he remains committed to contributing to the tech and startup community. Medved’s firm, OurCrowd, has been a significant backer of many startups, including Anthropic and Beyond Meat, and has a network of 240,000 accredited investors across 195 countries. In light of his diagnosis, Medved is now relying on technologies developed by startups he once supported to improve his quality of life. Technologies from companies like D-ID and ElevenLabs are helping him preserve his voice and communication abilities. Medved’s story underscores the profound personal and professional impact of the startup ecosystem he helped build.



